Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

PBX1 as Pioneer Factor: A Case Still Open.

Grebbin BM, Schulte D.

Front Cell Dev Biol. 2017 Feb 14;5:9. doi: 10.3389/fcell.2017.00009. eCollection 2017. Review.

2.

Comparative genomics reveals multistep pathogenesis of E2A-PBX1 acute lymphoblastic leukemia.

Duque-Afonso J, Feng J, Scherer F, Lin CH, Wong SH, Wang Z, Iwasaki M, Cleary ML.

J Clin Invest. 2015 Sep;125(9):3667-80. doi: 10.1172/JCI81158. Epub 2015 Aug 24.

3.

Retrovirus-Mediated Expression of E2A-PBX1 Blocks Lymphoid Fate but Permits Retention of Myeloid Potential in Early Hematopoietic Progenitors.

Woodcroft MW, Nanan K, Thompson P, Tyryshkin K, Smith SP, Slany RK, LeBrun DP.

PLoS One. 2015 Jun 22;10(6):e0130495. doi: 10.1371/journal.pone.0130495. eCollection 2015.

4.

Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.

Somasundaram R, Prasad MA, Ungerbäck J, Sigvardsson M.

Blood. 2015 Jul 9;126(2):144-52. doi: 10.1182/blood-2014-12-575688. Epub 2015 May 19. Review.

5.

Bafilomycin A1 targets both autophagy and apoptosis pathways in pediatric B-cell acute lymphoblastic leukemia.

Yuan N, Song L, Zhang S, Lin W, Cao Y, Xu F, Fang Y, Wang Z, Zhang H, Li X, Wang Z, Cai J, Wang J, Zhang Y, Mao X, Zhao W, Hu S, Chen S, Wang J.

Haematologica. 2015 Mar;100(3):345-56. doi: 10.3324/haematol.2014.113324. Epub 2014 Dec 15.

6.

Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia.

Linger RM, Lee-Sherick AB, DeRyckere D, Cohen RA, Jacobsen KM, McGranahan A, Brandão LN, Winges A, Sawczyn KK, Liang X, Keating AK, Tan AC, Earp HS, Graham DK.

Blood. 2013 Aug 29;122(9):1599-609. doi: 10.1182/blood-2013-01-478156. Epub 2013 Jul 16.

7.

Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis.

Sarvaiya PJ, Schwartz JR, Hernandez CP, Rodriguez PC, Vedeckis WV.

Am J Hematol. 2012 Oct;87(10):969-76. doi: 10.1002/ajh.23283. Epub 2012 Jul 5.

8.

Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.

Burmeister T, Gökbuget N, Schwartz S, Fischer L, Hubert D, Sindram A, Hoelzer D, Thiel E.

Haematologica. 2010 Feb;95(2):241-6. doi: 10.3324/haematol.2009.011346. Epub 2009 Aug 27.

9.

Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.

Linger RM, DeRyckere D, Brandão L, Sawczyn KK, Jacobsen KM, Liang X, Keating AK, Graham DK.

Blood. 2009 Sep 24;114(13):2678-87. doi: 10.1182/blood-2009-03-209247. Epub 2009 Jul 30. Retraction in: Blood. 2012 Aug 16;120(7):1533.

11.

Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1.

Jeha S, Pei D, Raimondi SC, Onciu M, Campana D, Cheng C, Sandlund JT, Ribeiro RC, Rubnitz JE, Howard SC, Downing JR, Evans WE, Relling MV, Pui CH.

Leukemia. 2009 Aug;23(8):1406-9. doi: 10.1038/leu.2009.42. Epub 2009 Mar 12.

12.

E47 controls the developmental integrity and cell cycle quiescence of multipotential hematopoietic progenitors.

Yang Q, Kardava L, St Leger A, Martincic K, Varnum-Finney B, Bernstein ID, Milcarek C, Borghesi L.

J Immunol. 2008 Nov 1;181(9):5885-94.

13.

Critical role for a single leucine residue in leukemia induction by E2A-PBX1.

Bayly R, Murase T, Hyndman BD, Savage R, Nurmohamed S, Munro K, Casselman R, Smith SP, LeBrun DP.

Mol Cell Biol. 2006 Sep;26(17):6442-52.

14.

High incidence of proviral integrations in the Hoxa locus in a new model of E2a-PBX1-induced B-cell leukemia.

Bijl J, Sauvageau M, Thompson A, Sauvageau G.

Genes Dev. 2005 Jan 15;19(2):224-33.

16.

The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells.

Thorsteinsdottir U, Krosl J, Kroon E, Haman A, Hoang T, Sauvageau G.

Mol Cell Biol. 1999 Sep;19(9):6355-66.

17.

Biology and treatment of adult acute lymphoblastic leukemia.

Levitt L, Lin R.

West J Med. 1996 Feb;164(2):143-55. Review.

18.
20.

High molecular weight DNA from fixed cytogenetic preparations.

Barker PE, Testa JR, Parsa NZ, Snyder R.

Am J Hum Genet. 1986 Nov;39(5):661-8.

Supplemental Content

Support Center